| Date Filed | Type | Description |
| 01/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/09/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 12/28/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 12/28/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 12/28/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 12/20/2022 |
4
| Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 27,000 shares
@ $1.1719, valued at
$31.6k
|
|
| 12/20/2022 |
4
| WEINSTEIN ROBERT (CFO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 27,000 shares
@ $1.1719, valued at
$31.6k
|
|
| 12/20/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 19,012 shares
@ $1.1719, valued at
$22.3k
|
|
| 12/20/2022 |
4
| SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 20,250 shares
@ $1.1719, valued at
$23.7k
|
|
| 12/20/2022 |
4
| Alkon Daniel L. (President and CSO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 19,688 shares
@ $1.1719, valued at
$23.1k
|
|
| 12/20/2022 |
4
| Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 22,500 shares
@ $1.1719, valued at
$26.4k
|
|
| 12/20/2022 |
4
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 27,000 shares
@ $1.1719, valued at
$31.6k
|
|
| 12/16/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 12/16/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/01/2022 |
4/A
| WEINSTEIN ROBERT (CFO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 75,000 options to buy
@ $6.07, valued at
$455.3k
|
|
| 12/01/2022 |
4/A
| Alkon Daniel L. (President and CSO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 43,750 shares
@ $0 |
|
| 12/01/2022 |
4/A
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 42,250 shares
@ $0 |
|
| 12/01/2022 |
4/A
| Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 75,000 options to buy
@ $6.07, valued at
$455.3k
|
|
| 12/01/2022 |
4/A
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 75,000 options to buy
@ $6.07, valued at
$455.3k
|
|
| 12/01/2022 |
4/A
| Alkon Daniel L. (See Remark) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 75,000 options to buy
@ $6.07, valued at
$455.3k
|
|
| 12/01/2022 |
4/A
| Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 75,000 options to buy
@ $6.07, valued at
$455.3k
|
|
| 12/01/2022 |
4/A
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 68,850 options to buy
@ $6.07, valued at
$417.9k
|
|
| 11/22/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 11/22/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ... |
| 11/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 11/17/2022 |
4
| Bernstein Bruce (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 80,000 options to buy
@ $6.07, valued at
$485.6k
|
|
| 11/17/2022 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 144,000 options to buy
@ $6.07, valued at
$874.1k
|
|
| 11/17/2022 |
4
| WEINSTEIN ROBERT (CFO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 96,000 options to buy
@ $6.07, valued at
$582.7k
|
|
| 11/17/2022 |
4
| Alkon Daniel L. (See Remarks) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 112,000 options to buy
@ $6.07, valued at
$679.8k
|
|
| 11/17/2022 |
4
| Singer William S. (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 96,000 options to buy
@ $6.07, valued at
$582.7k
|
|
| 11/17/2022 |
4
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 112,000 options to buy
@ $6.07, valued at
$679.8k
|
|
| 11/17/2022 |
4
| SCHECHTER JONATHAN (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 72,000 options to buy
@ $6.07, valued at
$437k
|
|
| 08/25/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/25/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
|